Free Range Discontinuation

.

Since 2005, Zoobiotic Ltd. (trading as BioMonde) has strived to provide its customers with a varied product range that provides value and delivers a successful outcome. We have been dedicated to supporting our customers to achieve this through the provision of expert clinical and product education and advice. Our BioBag products have grown in popularity and have built the trust and confidence of our customers and Free Range now comprises of less than 4% of usage. Due to regulatory and supply constraints it is no longer commercially viable for us to manufacture and supply Free Range larvae so we will be discontinuing them from our product line effective from the 1st of January 2021. Our BioBag range remains unaffected and will continue to be available.

The concept of bagged larvae was introduced in 1999 and has since proven itself to be equally effective as Free Range but has additional benefits including of ease of use, increased patient acceptance, improved infection control (containment), rapid application and removal, and ease of wound assessment. Due to the available published evidence and our experience supporting thousands of treatments we are confident that most of your non-healing and infected wounds deemed suitable for Free Range larvae can be appropriately treated using BioBag.

Research Collaboration

.

With the generous innovation and research contribution of £12,000 from the ERDF (European Regional Development Fund) BioMonde is completing research on the structure and effect of larvae secretions of the fly strain Lucilia sericata. This EU grant funding supports BioMonde’s commitment to research and development to meet unmet market needs through the understanding of the capabilities of the natural power of larvae. This funding provides BioMonde with an opportunity to complete in-vitro testing of larval secretions to identify future product application opportunities. BioMonde is dedicated to successful outcomes for patients and this fund allows BioMonde to invest in the future of larvae in healthcare and support the growth of manufacturing in South Wales.

WG Logo

Brexit Update:

The United Kingdom formally leaves the European Union on 31 January 2020 with a Withdrawal Agreement.
We will continue to supply all customers as currently during the Transition Period.

For any further information, or if you have any questions which are unanswered here, please contact our Customer Services team on 0345 230 1810 or info@biomonde.com
Any updates regarding the issue of the United Kingdom leaving the European Union will be provided here. 

Wound Care Today 2020

.

We're pleased to be kicking off our 2020 conference schedule by exhibiting at Wound Care Today 2020.

Wound Care Today offers delegates a unique learning platform, FREE of charge, to enhance their delivery of care through clinical updates, personal development, practical learning zones and networking in a friendly and open environment.

The event takes place on February 26th & 27th at the Marshall Arena, Milton Keynes and you can book your free place at the event by registering here: https://www.woundcare-today.com/events/book/5

BioMonde will be exhibiting on both days so please join us on stand 4 if you're in attendance.

Wounds UK Annual Conference 2019: larval therapy in lower limb wounds

.

BioMonde is once again looking forward to supporting Wounds UK and exhibiting at the Annual Conference in Harrogate.

The event continues to be the largest exhibition of Wound Care companies in the UK with more than 1,300 visitors expected over three days. With over 17 hours of fresh clinical content scheduled, the conference takes place between 4-6 November 2019 and BioMonde is pleased to be exhibiting for the duration of the event.

If you're attending Wounds UK this year, please join us on stand 27 to discuss our range of Larval Therapy products and to learn more about their usage in lower limb wounds. There will also be a symposium (hosted by Duncan Stang & Jemell Geraghty) on Tuesday 5 November which focuses on the appropriate and effective use of Larval Therapy in lower limb wounds:

 BM397 UK EN 01 1019 (Wounds UK Symposium 2019)

TVS 2019 - The Conference

.

BioMonde is once again looking forward to supporting the Tissue Viability Society and exhibiting at TVS 2019 - The Conference.

The annual conference, which is a flagship event for the society, is taking place on the 1st & 2nd May at St Mary's Stadium, Southampton. The event attracts delegates from across the UK and boasts an agenda which covers all areas of tissue viability including politics, research & innovation, leadership, clinical practice and multidisciplinary working.

BioMonde will be exhibiting at the event on both days so please join us on stand 50 to learn more about our larval debridement therapy products and the range of support services available.

TVS 2019: https://tvs.org.uk/2019-conference/

TVS2019smallest

BioMonde Logo Small     Cookie PolicyPrivacy & TermsContact
Copyright © 2020 BioMonde. All Rights Reserved.
BioMonde, Units 2-4 Dunraven Business Park, Coychurch Road, Bridgend, CF31 3BG, United Kingdom.

   European Regional Development Fund